Cargando…

Pan-cancer analysis identifies ITIH1 as a novel prognostic indicator for hepatocellular carcinoma

Although a previous pan-cancer study has reported the expression patterns of ITIHs in various tumors, their analyses have been restricted to limited cancer types. We thus comprehensively analyzed the expression profiles and clinical significances of ITIHs in a broader spectrum of cancers from TCGA....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Qing-hua, Mao, Ting, Tao, Yan, Dong, Tao, Tang, Xuan-xuan, Ge, Guo-hong, Xu, Zi-jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109120/ https://www.ncbi.nlm.nih.gov/pubmed/33744857 http://dx.doi.org/10.18632/aging.202765

Ejemplares similares

Integrative analyses indicate an association between ITIH3 polymorphisms with autism spectrum disorder
por: Xie, Xinyan, et al.
Publicado: (2020)

Integrative Analysis Identifies Cell-Type-Specific Genes Within Tumor Microenvironment as Prognostic Indicators in Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2022)

ITIH5 mediates epigenetic reprogramming of breast cancer cells
por: Rose, Michael, et al.
Publicado: (2017)

Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study
por: Nakamura, Naohiko, et al.
Publicado: (2019)

Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5
por: Young, Eric D., et al.
Publicado: (2020)

ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism
por: Pihl, Rasmus, et al.
Publicado: (2021)

ITIH4: A New Potential Biomarker of “Toxin Syndrome” in Coronary Heart Disease Patient Identified with Proteomic Method
por: Xu, Hao, et al.
Publicado: (2013)

Pan-cancer analysis identifies FAM49B as an immune-related prognostic maker for hepatocellular carcinoma
por: Xu, Feng, et al.
Publicado: (2022)

Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia
por: Oing, Christoph, et al.
Publicado: (2011)

Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma
por: Xu, Yingyu, et al.
Publicado: (2023)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
por: Zhang, Qifan, et al.
Publicado: (2021)

Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma
por: Dai, Kunfu, et al.
Publicado: (2022)

Effects of Helicobacter pylori infection and interleukin 6 on the expression of ITIH4 in human gastric cancer cells
por: Jing, Dadao, et al.
Publicado: (2020)

ITIH5-Derived Polypeptides Covering the VIT Domain Suppress the Growth of Human Cancer Cells In Vitro
por: Rose, Michael, et al.
Publicado: (2022)

Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
por: Zhou, Libo, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis of PTGES3 and its prognostic role in hepatocellular carcinoma
por: Wang, Han, et al.
Publicado: (2023)

Prognostic Pathways Guide Drug Indications in Pan-Cancers
por: Meng, Fanlin, et al.
Publicado: (2022)

Downregulation of ITIH3 contributes to cisplatin-based chemotherapy resistance in ovarian carcinoma via the Bcl-2 mediated anti-apoptosis signaling pathway
por: Liu, Yingzhao, et al.
Publicado: (2022)

Autophagy-Related Signatures as Prognostic Indicators for Hepatocellular Carcinoma
por: Ye, Wen, et al.
Publicado: (2022)

Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection
por: Shu, Qing‐Hua, et al.
Publicado: (2016)

RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival
por: Dong, Zhao-Ru, et al.
Publicado: (2021)

Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma
por: Zhong, Zhiwei, et al.
Publicado: (2023)

ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion
por: Huang, Shenglan, et al.
Publicado: (2022)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
por: Zhang, Fang, et al.
Publicado: (2023)

Long Non-coding RNA ITIH4-AS1 Accelerates the Proliferation and Metastasis of Colorectal Cancer by Activating JAK/STAT3 Signaling
por: Liang, Chaojie, et al.
Publicado: (2019)

Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma
por: Huang, Xueshan, et al.
Publicado: (2023)

Long noncoding RNA LINC00261 upregulates ITIH5 to impair tumorigenic ability of pancreatic cancer stem cells
por: Zou, Lijuan, et al.
Publicado: (2021)

Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases
por: Laursen, Tea Lund, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma
por: Shi, Ting, et al.
Publicado: (2022)

Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
por: Yamamoto, Masateru, et al.
Publicado: (2019)

A bile acid-related prognostic signature in hepatocellular carcinoma
por: Zhang, Wang, et al.
Publicado: (2022)

Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis
por: Miao, Yan-Dong, et al.
Publicado: (2022)

Objective to identify and verify the regulatory mechanism of DTNBP1 as a prognostic marker for hepatocellular carcinoma
por: Cheng, Xianyi, et al.
Publicado: (2022)

Systemic Expression Analysis Reveals Prognostic Significance of WIPI3 in Hepatocellular Carcinoma
por: Liang, Tao-tao, et al.
Publicado: (2020)

Comprehensive Genomic Profiling Identifies FAT1 as a Negative Regulator of EMT, CTCs, and Metastasis of Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2023)

Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection
por: Wu, Wenlong, et al.
Publicado: (2021)

CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma
por: Che, Yibin, et al.
Publicado: (2022)

The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

3065 A1BG and ITIH4 proteins are upregulated on HDL of youth with type 1 diabetes and correlate with glycemic control
por: Gourgari, Evgenia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_llecd2l7bt3u9sn6ljdve958n3